Hereditary bladder cancer

References

• Thelen A, Schaeuble J. Gleichzeitiges Vorkommen von BlasenpapiIlomen bei eineiigen ZwiIlingen. Z Urol 1957; 50: 188–95
   PubMedGoogle Scholar
• Fraumeni JF, Jr, Thomas LB. Malignant bladder tumors in a man and his three sons. JAMA 1967; 201: 507
   Web of Science ®Google Scholar
• Benton B, Henderson BE. Environmental exposure and bladder cancer in young males. J Natl Cancer Inst 1973; 51: 269–70
   PubMedGoogle Scholar
• McCullough DL, Lamm DL, McLaughlin AP, III, Gittes RF. Familial urothelial cell carcinoma of the bladder. J Urol 1975; 113: 629–35
   PubMed Web of Science ®Google Scholar
• Lynch HT, Walzak MP, Fried R, Domina AH, Lynch JF. Familial factors in bladder carcinoma. J Urol 1979; 122: 458–61
   PubMed Web of Science ®Google Scholar
• Mahboubi AO, Ahlvin RC, Mahboubi EO. Familial aggregation of urothelial carcinoma. J Urol 1981; 126: 691–2
   PubMed Web of Science ®Google Scholar
• Purtilo DT, McCarthy B, Yang JP, Friedell GH. Familial urinary bladder cancer. Semin Oncol 1979; 6: 254–6
   PubMed Web of Science ®Google Scholar
• Aben KK, Macville MV, Smeets DF, Schoenberg MP, Witjes JA, Kiemeney LA. Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma. Urology 2001; 57: 266–9
   PubMed Web of Science ®Google Scholar
• Kramer AA, Graham S, Burnett WS, Nasca P. Familial aggregation of bladder cancer stratified by smoking status. Epidemiology 1991; 2: 145–8
   PubMedGoogle Scholar
• Kiemeney LA, Moret NC, Witjes JA, Schoenberg MP, Tulinius H. Familial urothelial cell carcinoma among the population of Iceland. J Urol 1997; 157: 1649–51
   PubMed Web of Science ®Google Scholar
• Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA. Familial aggregation of urothelial cell carcinoma. Int J Cancer 2002; 98: 274–8
   PubMed Web of Science ®Google Scholar
• Murta-Nascimento C, Silverman DT, Kogevinas M, Garcia-Closas M, Rothman N, Tardon A, et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?. Cancer Epidemiol Biomarkers Prev 2007; 16: 1595–600
   PubMed Web of Science ®Google Scholar
• Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600–8
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78–85
   PubMed Web of Science ®Google Scholar
• Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001; 92: 144–50
   PubMed Web of Science ®Google Scholar
• Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002; 99: 260–6
   PubMed Web of Science ®Google Scholar
• Aben KK, Baglietto L, Baffoe-Bonnie A, Coebergh JW, Bailey-Wilson JE, Trink B, et al. Segregation analysis of urothelial cell carcinoma. Eur J Cancer 2006; 42: 1428–33
   PubMed Web of Science ®Google Scholar
• Aben KK, Cloos J, Koper NP, Braakhuis BJ, Witjes JA, Kiemeney LA. Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma. Int J Cancer 2000; 88: 493–6
   PubMed Web of Science ®Google Scholar
• Kiemeney LA, Kuiper RP, Pfundt R, van Reijmersdal S, Schoenberg MP, Aben KK, et al. No evidence for large-scale germline genomic aberrations in hereditary bladder cancer patients with high-resolution array-based comparative genomic hybridization. Cancer Epidemiol Biomarkers Prev 2006; 15: 180–3
   PubMed Web of Science ®Google Scholar
• Chan H, Pratt CB. A new familial cancer syndrome? A spectrum of malignant and benign tumors including retinoblastoma, carcinoma of the bladder, and other genitourinary tumors, thyroid adenoma, and a probable case of multifocal osteosarcoma. J Natl Cancer Inst 1977; 58: 205–7
   PubMedGoogle Scholar
• Aherne G. Retinoblastoma associated with other primary malignant tumours. Trans Opthalmol Soc UK 1974; 94: 938–44
   PubMedGoogle Scholar
• Tarkkanen A, Karjalainen K. Excess of cancer deaths in close relatives of patients with bilateral retinoblastoma. Ophthalmologica 1984; 189: 143–6
   PubMed Web of Science ®Google Scholar
• DerKinderen DJ, Koten JW, Nagelkerke NJ, Tan KE, Beemer FA, Den Otter W. Non-ocular cancer in patients with hereditary retinoblastoma and their relatives. Int J Cancer 1988; 41: 499–504
   PubMed Web of Science ®Google Scholar
• Sanders BM, Jay M, Draper GJ, Roberts EM. Non-ocular cancer in relatives of retinoblastoma patients. Br J Cancer 1989; 60: 358–65
   PubMed Web of Science ®Google Scholar
• Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004; 96: 357–63
   PubMedGoogle Scholar
• Liang SX, Lakshmanan Y, Woda BA, Jiang Z. A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma. Arch Pathol Lab Med 2001; 125: 1231–4
   PubMed Web of Science ®Google Scholar
• Bleoo SL, Godbout R, Rayner D, Tamimi Y, Moore RB. Leiomyosarcoma of the bladder in a retinoblastoma patient. Urol Int 2003; 71: 118–21
   PubMed Web of Science ®Google Scholar
• Venkatraman L, Goepel JR, Steele K, Dobbs SP, Lyness RW, McCluggage WG. Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma. J Clin Pathol 2003; 56: 233–6
   PubMed Web of Science ®Google Scholar
• Guo Z, Linn JF, Wu G, Anzick SL, Eisenberger CF, Halachmi S, et al. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat Med 2004; 10: 374–81
   PubMed Web of Science ®Google Scholar
• Schoenberg M, Kiemeney L, Walsh PC, Griffin CA, Sidransky D. Germline translocation t(5;20)(p15;q11) and familial urothelial cell carcinoma. J Urol 1996; 155: 1035–6
   PubMed Web of Science ®Google Scholar
• Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, Willems JL, Swinkels DW, et al. CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas. Int J Cancer 2005; 116: 282–4
   PubMed Web of Science ®Google Scholar